Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
European Journal of Medicinal Chemistry|September 20, 2025
Overcoming EGFR mutation resistance: Dual inhibition strategies using TKIs in non-small cell lung cancer therapyJeevitha Sivam, Azhar Ariffin, Ajantha Sinniah, et al.
Biochemical and Biophysical Research Communications|September 12, 2024
Synergistic anti-tumorigenic effect of diosmetin in combination with 5-fluorouracil on human colon cancer xenografts in nude miceSareh Kamran, Ajantha Sinniah, Zamri Chik, et al.
Molecules (Basel, Switzerland)|August 23, 2020
Annexin A1: A Bane or a Boon in Cancer? A Systematic ReviewThanusha Ganesan, Ajantha Sinniah, Zaridatul Aini Ibrahim, et al.
Cancer Gene Therapy|April 13, 2026
SPARC family proteins: matricellular modulators of cancer progression and therapeutic resistanceRachel Huey Xuan Hoe, Thamil Selvee Ramasamy, Ajantha Sinniah, et al.
Memorias Do Instituto Oswaldo Cruz|June 18, 2005
An overview of the effects of annexin 1 on cells involved in the inflammatory processAhmad M Kamal, Roderick J Flower, Mauro Perretti
Trends in Pharmacological Sciences|August 19, 2007
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?Saul Yedgar, Miron Krimsky, Yuval Cohen, et al.
Life Sciences|July 7, 2019
Antiproliferative and apoptotic activities of 8-prenylnaringenin against human colon cancer cellsSanaz Koosha, Zahurin Mohamed, Ajantha Sinniah, et al.
Prostaglandins & Other Lipid Mediators|November 30, 2011
Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory systemSamia Yazid, Lucy V Norling, Rod J Flower
British Journal of Pharmacology|June 16, 2004
Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophagesSimon Yona, Julia C Buckingham, Mauro Perretti, et al.
European Journal of Pharmacology|November 4, 2008
The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS)Christopher Bolton, Gwen S Scott, Terence Smith, et al.
Pageof 9